1. Pharmacokinetics of low-dose methotrexate in children receiving maintenance therapy for acute lymphoblastic leukaemia;Pinkerton, C.R.; Welshman, S.G.; Kelly, J.G.; Shanks, R.G.; Bridges, J.M.;Cancer Chemother Pharmacol,1982
2. Pharmacokinetics of oral methotrexate in children;Balis, F.M.; Savitch, J.L.; Bleyer, W.A.;Cancer Res,1983
3. Can food influence the absorption of methotrexate in children with acute lymphoblastic leukaemia?;Pinkerton, C.R.; Glasgow, J.F.T.; Welshman, S.G.; Bridges, J.M.;Lancet,1980
4. Presymptomatic central nervous system therapy in previously untreated childhood acute lymphoblastic leukaemia. Comparison of 1800 rad and 2400 rad;Nesbit, M.E.; Sather, H.N.; Robison, L.L.;Lancet,1981
5. Design and analysis of randomized clinical trials requiring prolonged observation of each patient;Peto, R.; Pike, M.C.; Armitage, P.;II Analysis and examples. Br J Cancer,1977